Justices Urged To Bar Passive Infringement For Skinny Labels

By Dani Kass · February 19, 2026, 9:04 PM EST

The Federal Circuit cleared the path for branded-drug makers to claim a rival induced infringement of a patent without taking any active steps to do so, Hikma told the U.S. Supreme...

To view the full article, register now.

Documents

Case Information

Case Title

Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Amarin Pharma, Inc., et al.

Case Number

24-889

Court

Supreme Court

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

February 19, 2025